Drug resistance in cancer treatment is a formidable challenge. Pharmacologists address this by developing combination therapies that attack cancer cells from multiple angles, reducing the likelihood of resistance. They also study the underlying mechanisms of resistance to develop next-generation inhibitors. Monitoring and adjusting treatment regimens based on patient response is another strategy used to combat resistance.